|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 17701004.8 (espacenet) (Federated) (European Patent Register), 20170111 | Patent/reg. no. and date | DK/EP 3402468, 20230726 | Publication date | 20181121 | Priority no. and date | US 201662277002 P, 20160111 | EP pub. no. and date |
EP 3402468 20181121 | Effective date | | Applicant/owner | Queen Mary University of London, Mile End Road
London E1 4NS, GB | Applicant ref. no. | | Inventor | WANG, Yaohe, Molecular Oncology Barts Cancer Institute Queen Mary University of London Ground Floor John Vane Science Centre
London EC1M 6BQ, GB, FERGUSON, Mark, Molecular Oncology Barts Cancer Institute Queen Mary University of London Ground Floor John Vane Science Centre
London EC1M 6BQ, GB, LEMOINE, Nicholas R, Molecular Oncology Barts Cancer Institute Queen Mary University of London Ground Floor John Vane Science Centre
London EC1M 6BQ, GB | Representative | | Opponent | | IPC Class | A61K 31/00 (2006.01) , A61K 35/76 (2015.01) | Title | INHIBITORS OF PI3K P-DELTA 110 FOR USE IN DELIVERY OF VIRUSES IN THE TREATMENT OF CANCER | Int. application no. | GB2017050051 | Int. publication no. | WO2017122000 | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |